688105.SS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:00):

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials...

Stats
Dagens volum	2.29M
Gjennomsnittsvolum	2.57M
Markedsverdi	11.10B
EPS	CNY0.0100 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-699.00
ATR14	CNY0.0840 (0.30%)

Volum Korrelasjon

Lang: -0.04 (neutral)

Kort: -0.45 (neutral)

Signal:(45.344) Neutral

Nanjing Vazyme Biotech Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Nanjing Vazyme Biotech Korrelasjon - Valuta/Råvare

-0.69
( moderate negative )

-0.72
( moderate negative )

0.00
( neutral )

-0.66
( moderate negative )

0.22
( neutral )

0.46
( neutral )

Nanjing Vazyme Biotech Økonomi

Annual	2023
Omsetning:	CNY1.28B
Bruttogevinst:	CNY822.18M (64.05 %)
EPS:	CNY-0.180

FY	2023
Omsetning:	CNY1.28B
Bruttogevinst:	CNY822.18M (64.05 %)
EPS:	CNY-0.180

FY	2022
Omsetning:	CNY3.57B
Bruttogevinst:	CNY2.46B (68.88 %)
EPS:	CNY1.490

FY	2021
Omsetning:	CNY1.87B
Bruttogevinst:	CNY1.52B (81.22 %)
EPS:	CNY1.870

Financial Reports:

No articles found.

Nanjing Vazyme Biotech

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.